Highlights in International Tobacco Giants' Financial Reports for 2023FY

Industry Insight by 2FIRSTS, edited by Sophia
Feb.28.2024
Highlights in International Tobacco Giants' Financial Reports for 2023FY
BAT, PMI, and JTI release Q4 and annual financial reports for 2023, highlighting performance and future strategies in new tobacco.

In early February, British American Tobacco (BAT), Philip Morris International (PMI), and Japan Tobacco International (JTI) each released their financial reports for the fourth quarter and full year of 2023. The reports included a review and disclosure of their performance for the year, as well as a partial unveiling of the Annual Operation Plan for the upcoming fiscal year.

 

Based on the financial reports, 2FIRSTS conducted a review and analysis of the performance and future development strategies of three international tobacco companies in the new tobacco sector in 2023.

 

 

IQOS Continues to Lead in Shipment Volume of NTPs, BAT Demonstrates Outstanding Profitability

 

Three international tobacco companies have given different names to their new tobacco businesses. For example, BAT refers to it as "New categories" (NC), which includes vaping, HNB, and oral products; while PMI calls it Heated Tobacco Units (HTU) and JTI refers to it as "Reduced-Risk Products" (RRP).

 

In a comparative analysis of three international tobacco companies, in 2023, the unit shipments of PMI were 125.2 billion, surpassing those of BAT at 29.7 billion and JTI at 8.8 billion. PMI's new tobacco product volume is three times greater than the combined total of BAT and JTI, giving it a significant competitive advantage.

 

The new tobacco segment of three international tobacco companies saw varying increases in shipments in 2023. PMI recorded a 14.7% increase, JTI recorded an 11.8% increase, and BAT recorded the smallest increase of 3.8% among the three.

 

Noteworthy is the decrease in BAT's heated tobacco products (HTP) recorded report, at -1.3%. The growth was mainly driven by aerosol products (7%) and oral/dissolvable products (33.6%); despite slow growth in shipment volume, the increase in revenue far exceeded this, with NC's organic revenue growth reaching 21.0%. The unit profitability is worth noting.

 

BAT: VUSE Drives "New Category", Calling for U.S. to Strengthen Compliant Markets

 

BAT released its 2023 financial report on February 8, showing a 1.3% overall decrease in revenue for the BAT group, offset by a 21.0% increase in organic revenue from "new categories." According to BAT, this strong momentum was driven by sales of Vuse and Velo.

 

The new category products performed well in different regional markets. In the traditionally strong BAT market of Europe and America (AME), the profits from the new category reached £1.67 billion. Meanwhile, the emerging markets in Asia Pacific, Middle East, and Africa (APMEA) also showed strong performance, with profits reaching £610 million.

 

In 2023, revenue from non-combustible products now accounts for 16.5% of BAT Group's income. In their financial report, BAT stated that "vape is the fastest-growing smoking alternative, with Vuse leading the global market for vape products, and described glo as the No.2 player in the HNB sector." Velo was labeled as "the least harmful product in the new category."

 

Highlights in International Tobacco Giants' Financial Reports for 2023FY
British American Tobacco positions its various product lines under its new tobacco division | Image source: British American Tobacco 2024 financial report

 

In the business of BAT, new categories have now become strong enough to offset the lackluster performance of the combustible segment. The group is expected to deepen its new tobacco layout in the foreseeable future, especially in its strategically advantageous compliant markets. In its financial report, BAT specifically pointed out that the group "welcomes the increased enforcement efforts by the US Food and Drug Administration (FDA) and other federal and state government agencies, taking more measures to prevent the illegal sale of flavored disposable e-cigarettes in the United States," urging the FDA and other agencies to accelerate market compliance in the United States to maximize its compliance advantage and strengthen market share.

 

PMI: Sluggish Growth in Shipments of IQOS, which will Undergo Test Run in U.S. in 2024

 

On the other hand, PMI, which also released its financial report on February 8, announced the impressive performance of its new tobacco products. In 2023, PMI's IQOS user base is estimated to be around 28.6 million, an increase of 3.7 million compared to December 2022. IQOS's market share in the HNB market increased by 1.2% for the full year, reaching 9.1%. CEO Jacek Olczak stated that IQOS's net revenue has exceeded that of classic cigarette brand Marlboro in this fiscal year.

 

However, even though income has surpassed, the shipment growth of IQOS has begun to slow down after years of rapid growth, causing concern among observers. Throughout the year 2023, the entire heated tobacco segment of PMI saw a growth rate of 14.7%, compared to 14.9% in 2022, showing a slight overall decline; PMI stated that the slowdown is mainly due to the EU's ban on flavored heated tobacco, and they forecast that shipment volumes in 2024 will be further impacted.

 

Highlights in International Tobacco Giants' Financial Reports for 2023FY
Comparison of PMI's heated tobacco and cigarette performance | Source: PMI 2024 financial report

 

However, Alzack remains optimistic about the future performance of the group's new tobacco products. In a statement, he said the company is "entering 2024 with strong momentum." As of December 31, 2023, PMI's smoke-free products were being sold in 84 markets. In the past year, the amortization of intangible assets acquired by PMI amounted to $0.42 per share, including the agreement reached with Altria on the commercialization rights of IQOS in the United States, which will come into effect on May 1, 2024. By then, IQOS will also officially "test the waters" in the United States about a decade after its initial launch.

 

The American market, which has been "educated" by vaping for many years, is now eagerly anticipating how it will receive HNB products, making it one of the most closely watched trends in the industry for the coming year.

 

JT: Increased Investment in Ploom and Continued Expansion of International Market for HTPs

 

At the same time, JT, which released its financial report later on February 13, reported that in the past fiscal year 2023, JT Group's performance reached record levels across all financial indicators. JT attributed its outstanding performance to "growth in market share in Japan" and "marketing efforts driving sales growth".

 

According to the financial report, over the past year, positive changes in trading volume have been driven by the growth in market share of Ploom X in Japan, especially as Ploom continues to increase its market share. The release of the Ploom X ADVANCED in November further enhanced consumer adoption and retention, leading to a continued increase in market share in the increasingly competitive field of heated tobacco systems (HTS) in Japan, reaching 11.4%.

 

Meanwhile, over the past year, JT has continuously expanded the geographical coverage of its HNB product Ploom X. By the end of 2023, Ploom X had entered 13 markets; in Japan, JT Group's market share in the heated tobacco segment reached 11.4% in December 2023.

 

It is worth noting that among the three major international tobacco companies, JTI is the only company that saw an increase in sales of combustible cigarettes. According to Bloomberg, the company manufactured and shipped over 531 billion combustible cigarettes last year, with a total sales volume increase of 2.3% for JTI's Winston and Camel brands in 2023. In comparison, PMI's cigarette shipments in 2023 were 613 billion, a decrease of 1.3% from the previous year; while BAT's shipments were 555 billion, an 8.2% decrease from 2022.

 

The difference in sales highlights the strategic and priority differences within JTI. While PMI and BAT are directing more research and marketing resources towards alternative products including e-cigarettes, heated tobacco, and nicotine pouches, JTI appears to be more focused on trying to increase market share and sales in traditional cigarettes. However, the group still announced in its financial report that it will increase investments in heated tobacco, including Ploom. According to the financial report, JT's target is to cover approximately 80% of global HTS demand by the end of 2025, and they plan to introduce Ploom X into over 40 markets globally by the end of 2026.

 

Highlights in International Tobacco Giants' Financial Reports for 2023FY
Ploom Performance Targets | Image source: Japan Tobacco 2024 Financial Report

 

In response, Duncan Fox, an analyst at the Bloomberg Intelligence, pointed out that increasing investment in Ploom "is reasonable, but if it is to overcome established competition, it may be too late." He mentioned that the conversion of this investment will take time and projected that "JT's operating profit will decline in 2024," while "Ploom will not achieve profitability until 2028."

 

2FIRSTS will continue to monitor the latest developments from major tobacco companies in the new year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives